GOSS

Gossamer Bio Inc

7.46 -0.36 (-4.60%)

Delayed Prices By NASDAQ, in USD Market Closed

Trade

7.44

7.48

Overview

Prev Close7.46

Day's Range 7.34 - 7.74

52 Week Range 6.25 - 14.26

Average Volume (3m)843.85K

1-Year Return-17.39%

Beta1.0374

Market Cap603.05M

P/E Ratio

Revenue0

EPS-3.1105

Dividend (Yield) (0%)

1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max

Sector
Health Technology

Industry Pharmaceuticals Major

CEO Faheem Hasnain

Employees 185

FINANCIAL SUMMARY

For the quarter ended 31/3/2022, Gossamer Bio Inc's revenues decreased by NaN and amounted to 0.00. Net income decreased by 2.67% to -57.79M. Net assets decreased by 75.17% to 30.16M and EPS decreased from -0.74 to -0.76.

GOSS's Investor Relations

Income StatementBalance SheetCash Flow Statement

Quarterly

N/A

116.90%

06/21

09/21

12/21

03/22

-1.3M

-1.31M

-1.28M

-1.1M

-55.58M

-55.65M

-51.65M

-54.32M

-59.83M

-60.25M

-56.28M

-57.79M